Thank you for being an amazing role model and mentor to myself and so many young women. Thank you for teaching me about liver disease and inspiring me to become a hepatologist when I was just an intern. Thank you for introducing me to all these amazing young investigators and

Join Yale Liver Cancer Program experts: Mario Strazzabosco, Simona Jakab, Catherine Mezzacappa, MD MPH, Dr. Tamar Taddei + Dr. Ariel Jaffe at the American Liver Foundation National Connecticut #PrimaryCare Consortium: ➡️Wed., March 20, 6-8pm ➡️Cromwell, CT RSVP: [email protected] Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp

Humbled to receive T32 equivalent funding for my future research during GI fellowship! Such initiatives are unparalleled milestones in supporting international medical trainees. Thank you, YSM OPSSD Yale Internal Medicine YaleMedPSTP Yale Digestive Diseases for the honor.

Diabetes and glycemic control impact the risk of liver cancer From two independent cohorts Hepatology Communications 1. UK Biobank: journals.lww.com/hepcomm/fullte… 2. US veterans: journals.lww.com/hepcomm/fullte… Editorial from Chen and Jennifer Flemming: journals.lww.com/hepcomm/fullte… #livertwitter

A memorable and meaningful weekend - many thanks to ACG leaders for this initiative!

Blood-based #colorectalcancer screening tests have made big news this month. Two modeling studies & expert consensus published this week in Gastroenterology and CGH shed new light on the promise & peril of liquid biopsy for CRC screening. Read our take ➡️ow.ly/xTmS50R4ZIk

Being an Gastroenterology editorial fellow has truly been a highlight of this year for me - I highly recommend applying to anyone interested in research!

Out now 💥 pragmatic RCT which found higher HCV cure rates with facilitated telemedicine integrated into opioid treatment programs led by Dr. Andrew Talal at UBuffalo. Proud to be part of this study. Michigan Hepatology MountSinaiLiver #livertwitter

If you want to change behavior, show the data. So proud of Anahita Rabiee adding to evidence behind safety of naltrexone in cirrhosis. Among 2940 patients with cirrhosis started on naltrexone for AUD, zero cases of DILI was identified! #livertwitter sciencedirect.com/science/articl…

🌟NEW🌟 Gastroenterology no longer requires a payment for submissions of full-length original research articles, making it easier to submit your work.🚫💰 Submit your manuscript today! ➡️ ow.ly/cQhA50Rk98m

Please join us for our 11th Annual Endoscopy course in beautiful Newport - October 18-19, 2024 with an all-star lineup of speakers organized by Priya Jamidar & John Saltzman of Brigham and Women's GI. Scan the QR code to register for this dynamic event. Yale CME

📑 HCC is associated with #diabetes and longitudinal blood glucose control‼️ 🔴 Inadequate blood glucose control associated with ⬆️ risk of #HCC 🔑 Long-term glucose control should be considered in #cirrhosis care #LiverTwitter journals.lww.com/hepcomm/fullte…

Grateful for and inspired by this amazing group of women hepatologists ❤️Yale Digestive Diseases Guadalupe GarciaTsao Anahita Rabiee Meagan Alvarado Yale Liver Cancer Program

Case reports inaccurately reflect rates of severe acute liver injury. Incidence rates utilizing real-world data can be used to identify the most potentially hepatotoxic medications and offer a tool to investigate hepatotoxicity safety signals of drugs. ja.ma/4bneUI9

Natural language processing for finding people with steatotic / fatty liver 100% Sensitive 89% Positive predictive value A giant leap forward Hepatology Communications Open access: journals.lww.com/hepcomm/fullte… #livertwitter

In this study of patients with HCV-related cirrhosis who achieved HCV cure & subsequently developed hepatocellular carcinoma, remaining up to date with screening was linked with improved overall survival, supporting the screening of eligible individuals. ja.ma/4cUytJg